Member Info for CHELSEA7

Thanks Crumbs, and that is the key it will, when succesful it will add validation to the SCIB1 trial and Immunobody. SCIB2 I have marked down for H2 2020 following on from MOD1.

A fantastic year coming ahead with trials converging on one another and a new platform for us too. One thing for sure Vulpes must have really liked where we are at, I can understand why. Night buddy, seems like a long week again, looking forward to next.

Crumbs, not really about the U.S. Approval comimg now. My understanding is we have withdrawn the request for an IND, therefore cancelling the file, which will only be re-opened if we do re apply and pay for it to be so.

So in the absence of that, it will remain closed and the more I think about it, do we really need a trial there?? Keith Flaherty will have access to trial data if he chooses to do, and will comment on it as he did to the Mono Trial 5 years ago. In that he said the data was compelling, the trial was held here, is there any need I am not considering why we have to go there?

Evening Dracula, it caught my eye reading the requirements and qualifications on the Patient Enrolnenet, that the trial is down for a period of two years, that being the case, where does 2023 come from?

It seems the first data will collected after the first 12 weeks,adding a month for collation of data it seems reasonable we will get an update after 16 weeks, which is very good compared to some trials. The MOD1 trial will alse contain early databeing in we are treating solid tumours it won"t be long until we can update early findings.

Just queuring the 2023 ""end date"" could you explain where that comes from. Thanks.

Well a few people did today, 10 share chats and 16 trades, less is good at times. Been waiting to see a little bounce here for a few weeks, still pretty much range bound and I believe you have a presentation in Edinburgh on the 12th, the day of the Scancell AGM too. A little bounce for both will go down well i am sure.

Can anybody tell me why a few meetings have been in Edinburgh this year, not particularly accessible for many of you guys, but is there a reason. Good luck in the week to come..................c7

Tell me ""monetising our assets? Can that not be seen as what we have done with the Issuance of Equity to Vulpes? I think it is, somuch for semantice eh.

Goodnight ALL

So would I Ruck, believe me I am not complaining, but just 300k shares were bought by retail PIs, hence the drop from 101k.

We still have a few LTH holders who want to take their holdings to the 2m mark, at a few pence more even just to ensure we are back on a bull run. That is just one the reasons I am calling Level2 and dummy trades a smokescreen it is mainly for what is our seller and buyer and changes quickly on a few PI sells.

Crumbs, I am very hopeful it will be a very interesting AGM, the supposed frustration and bad feeling from PIs to the BOD is not even mentioned in the circles i mix with, and as you and I both say we are getting ever closer to the real IP gaining news, and we have never been closer to such a time for many years. I find it all very exciting, I will refrain from naming those with an agenda, simply because I find nothing in their postings relevant to what is occurring. Have never felt stronger that their bleatings are coming from a place of disruption aand personal gripes. Whatever the history between Ruch, Barmuda and Inanaco it is easy to miss they are in agreement with all the positive steps coming forward, and hope to the see the market reflect our advnces in the weeks to come.

The biggest validation of late is simply Vulpes deciding on joining us, I don"t believe for a second that involves just the £3.9m, but further investment will come dependant on the overall situation, and the first installment has given us time to prepare even more R & D and into human trials. The interest in us has only been boosted by the third platform interest and shows just how far we have come to arriving at this point, whilst some are stuck with the thoughts that we have been wasting valuable time awaiting the U,S,A FDA IND. Reasons to be happy? More every week, and more coming.

I thought we were keeping the rows to the ADVFN BB??

Never mind, well done steve for posting up details of the trial, well done Scancell on announcing our third platform, which just gives another angle on future funding whilst we scrutinise more data from clinical trials, to add to the previous RNS we are entering SCIB1 trial innediately which by the enrolment of first patient we had done anyway, as a few of us suggested here anyway.

Seems funny we have waited so long for news with skin in the game and the sentiment has been drained by "Team Negative"", to a large extent.

Four days to go the AGM, i am hoping for more news before it, but nobody can deny good news is starting to roll now as we expected. Have a good weekend all, I wonder how the next bit of good news will prove up ""we are a lifestyle company""!!, lol.

Have a good weekend all, and isn"t it odd thathalf of todays volume were buys and the MMs did not increase the shares they would take or the price they would pay, but in 5 trades from 7.60-7.022 we fell 4.52% in the market.

Ruck, there are actually 2 groups, the other group are reccing TF and Knowlesi, lol.

Still taking 120k shares at 7p, and that is after a 13k buy and a 64k buy. A smokescreen,

Buys 80k

Sells 102k

-4.52%?? Accomadating a buyer IMHO

Thanks Bermuda, I guess Southampton might be one.

For 64,300

Time for a bigger buy?

Interesting, I guess there is no particular reason why the remaining 19 patients cannot be enrolled to Nottingham University, and as far as the U.S.A. arm is concerned, well it would further save on resources.

No, but you did say it was not a good ""RNS"". I just think you entrench yourself in a position and regardless of whatever we find stick to it. ""Stubborn"" might be appropiate!!

Anyway, good night.

Still getting my head around this platform Rats, but it certainly can bring in sufficient income to cover our expenditure and future clinical trials. A very exciting platform, and a clear move into the ARMS scenario. I like it.

Buys 16k

Sellse 102k

Just 7 trades, 2 buys, 5 sells

It would benefit you TF to read a post .read an Rns or even digest the information before rushing to say you were right.

We all hope recruitment and dosing takes place immediately, not sure why you want it delayed so much?

Why is that Gilders??

Exactly. Still hopeful we will hear about patients enrolled and dosing before the AGM.

Quite how you conclude that is beyond me.

But being "right" is everything, eh!!?